AI meets sports nutrition: BASF-Nuritas collaboration yields plant-based peptide ingredient to modulate inflammation

636771043227772918idea light.jpg

06 Nov 2018 --- BASF has launched a sports nutrition ingredient containing a unique set of plant-based peptides identified using artificial intelligence (AI), for regulating inflammation. Coined PeptAIde, the ingredient was developed as part of a collaboration between BASF and biotech company Nuritas to discover new bioactive peptides to meet evolving consumer needs. Peptides are biologically occurring short chains of amino acids, with some acting as potent signaling molecules in the body.

With industrial-scale production in Germany, PeptAIde is now available in the US, while commercialization is set to follow in Asia Pacific and Europe by 2019. BASF is also currently performing regulatory clearance to allow access to other key markets.

Click to EnlargeThe collaboration between the two companies was announced in January 2017. Under the agreement, Nuritas used AI to identify PeptAIde’s new generation of peptides unlocked from rice protein. BASF has reportedly been granted an exclusive license to commercialize these peptides.

Inflammation is a key concern of active people as it may restrain their ability to continue with physical activity. Initiated by feelings of discomfort, inflammation is regulated by the secretion of a complex network of cytokines, which contributes to a fundamental response to injury and regulates recovery in the body.

BASF research indicates that consumption of PeptAIde affects cytokine release and has immune-modulating properties in consumers, potentially supporting physiological benefits after exercise. PeptAIde is vegan and does not use allergen materials. It also delivers a natural taste profile for flexible use in various sports nutrition formats.

“Exercise-induced muscle damage stimulates important inflammationmarkers including cytokines interleukin (IL)-6 and IL-10, and C-reactive protein (CRP). IL-6 increases rapidly during exercise whereas CRP responds much slower. Although the precise biological action of musclederived cytokines is still uncertain, IL-6 released from contracting muscle is important in regeneration,” Dietrich Rein, Scientific Marketing at BASF Human Nutrition, tells NutritionInsight.
“With PeptAIde we introduce a unique plant-based protein hydrolysate containing a set of peptides that specifically help modulate inflammation. To verify the biological significance, we performed in silico and cell culture tests. Both systems indicated promising effects in modulating inflammation markers relevant to regeneration after physical exercise,” he adds.
PeptAIde was also assessed in a 24-hour kinetic study in healthy volunteers. The results showed that PeptAIde was “well accepted” by the volunteers, the company reports. A single dose of 20g PeptAIde was found to transiently affect selected immune and inflammation markers assessed in blood plasma. These initial results indicate beneficial effects towards support of muscle stress response.

“Our research has shown that consumers today are seeking innovative, plant-based solutions to help them better manage sports-related inflammation,” says Tina Low, Vice President, Business Management BASF Human Nutrition. “PeptAIde’s unique properties will resonate very well with active consumers and enable our customers to take sports nutrition to the next level.”

PeptAIde will be presented at SupplySide West in Las Vegas this week.

To contact our editorial team please email us at

Related Articles

Health & Nutrition News

Preventative healthcare buzz: Nuritas and Pharmavite partner on bioactive peptides in supplements

16 Jan 2019 --- Irish biotech company Nuritas and supplement manufacturer Pharmavite have partnered in a bid to “transform” the dietary supplements industry. The partnership will combine Nuritas’ artificial intelligence (AI) technology with Pharmavite’s experience across multiple dosage forms. The news is the latest in a string of high profile partnerships for Nuritas, including BASF and Nestlé, and an indicator of Nuritas’ consumer strategy.  

Health & Nutrition News

The key nutritional themes of 2018: A year in review

20 Dec 2018 --- As the year draws to a close, NutritionInsight looks at the key trends that made headlines over the past 12 months. Digestive health remained a popular topic this year, with the industry seeing fiber and fermented foods further rising in demand, while personalized nutrition maintained its standing as an area of high interest. 2018 also marked the year of plant-based diets coming to the fore via the increasing popularity of meat and dairy alternative options combined with consumers’ need for more conscientious food choices. Protein enjoyed innovation and varying NPD, often within the sports nutrition market, but also in senior and medical nutrition.

Health & Nutrition News

EMA: Omega 3 fatty acid medicines no longer seen as effective in preventing heart disease

17 Dec 2018 --- The European Medicines Agency (EMA) has concluded that medicines containing omega 3 fatty acids are not effective in preventing further heart and blood vessel problems in patients who have had a heart attack. As a result of this finding, omega 3 fatty acid medicines will no longer be authorized for such use. These types of medicines had been authorized for use after a heart attack at a dose of 1g per day, in combination with other medicines, in several EU countries since 2000.

Health & Nutrition News

The future is now? Nuritas secures US$34m to accelerate healthcare solutions from AI and DNA analysis

03 Dec 2018 --- Irish biotech company Nuritas has secured a US$34m investment from the European Investment Bank (EIB) to increase and accelerate the development of artificial intelligence (AI) and DNA analysis to improve global healthcare. The investment follows Nuritas’ launch of PeptAIde earlier this year, in cooperation with BASF, which demonstrated how AI can accelerate the discovery of healthcare products. Future investment from EIB is to scale up development of new therapeutics in areas of interest including anti-aging, anti-inflammatory and diabetes treatment.

Health & Nutrition News

Medtronic to acquire medical data firm Nutrino Health to boost diabetes management offering

22 Nov 2018 --- Medtronic, a provider of medical technology, is to acquire Nutrino Health, a provider of nutrition-related data services, analytics and technologies. The announcement comes at a time when the industry is taking note of the potential of advanced technologies and big data to answer pertinent, global issues surrounding health and nutrition.  

More Articles